Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer

NCT00322517 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
90
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer